Prion

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:04, 1 February 2022) (edit) (undo)
 
(14 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='3haf' size='450' side='right' scene='Prion/Cv/3' caption='Human major prion protein complex with Cd+ (pink) and Cl- (green) ions (PDB code [[3haf]])'>
+
<StructureSection load='' size='350' side='right' scene='Prion/Cv/3' caption='Human major prion protein complex with Cd+ (pink) and Cl- (green) ions (PDB code [[3haf]])'>
{{Clear}}
{{Clear}}
-
'''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. The images at the left and at the right correspond to one representative prion, ''i.e.'' the crystal structure of human prion ([[3haf]]). For more details see<br />
+
__TOC__
 +
 
 +
==Function==
 +
 
 +
'''Prion''' (PrP) is a protein which becomes infectious upon undergoing conformation change to an amyloid form, which is self-propagating and becomes resistant to protease degradation. The fungus ''Podospora anserine'' has a prion-like protein HET-S which undergoes a conformation change to amyloid form which prevents its colony from merging with non-compatible colonies. Yeast prion proteins are Sup35 and Ure2. For more details see<br />
*[[Prion protein]]<br />
*[[Prion protein]]<br />
-
*[[Human Prion Protein Dimer]].<br />
+
*[[Human Prion Protein Dimer]]<br />
 +
*[[Doppel]]<br />
 +
*[[Group:SMART:A Physical Model of the Structure of GNNQQNY from Yeast Prion Sup35]]<br />
Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]).
Click here to see <scene name='Prion/Cv/2'>example of prion unfolding</scene> (morph was taken from [http://molmovdb.org/cgi-bin/movie.cgi Gallery of Morphs] of the [http://molmovdb.org Yale Morph Server]).
-
=== Dominant-negative Effects in Prion Diseases: Insights from Molecular Dynamics Simulations on <scene name='Journal:JBSD:4/Cv/2'>Mouse Prion Protein Chimeras</scene> <ref>doi 10.1080/07391102.2012.712477</ref>===
+
== Dominant-negative Effects in Prion Diseases==
 +
 
 +
Insights from Molecular Dynamics Simulations on <scene name='Journal:JBSD:4/Cv/2'>Mouse Prion Protein Chimeras</scene> <ref>doi 10.1080/07391102.2012.712477</ref>.
The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect.
The key event in prion diseases is the conformational conversion from the cellular form of the [[Prion_protein|prion protein]] (PrP<sup>C</sup>) to its pathogenic scrapie form PrP<sup>Sc</sup> (or prion). PrP<sup>Sc</sup> is the sole causative agent of prion diseases which self-propagates by converting PrP<sup>C</sup> to nascent PrP<sup>Sc</sup>. Mutations in the open reading sequence of the [[Prion_protein|prion protein]] gene can introduce changes in the protein structure and alter PrP<sup>Sc</sup> formation and propagation, possibly by (de)stabilizing the physiological folding of PrP<sup>C</sup> and/or affecting its interactions with some yet unknown cellular factors. Some PrP polymorphisms may even inhibit the wild-type (WT) PrP<sup>C</sup> from being converted to PrP<sup>Sc</sup>, with the so-called “dominant-negative” effect.
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The &#946;2-&#945;2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the &#946;2-&#945;2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>.
Here we use molecular dynamics simulations to investigate the structural determinants of the globular domain in engineered Mouse (Mo) PrP variants, in WT human (Hu) PrP (PDB: [[1hjn]]) and in WT MoPrP (PDB: [[1xyx]]). The Mo PrP variants investigated here contain one or two residues from ''Homo sapiens'' and are denoted “MoPrP chimeras”. <scene name='Journal:JBSD:4/Cv/3'>Some of them are resistant to PrP<sup>Sc</sup> infection</scene> <span style="color:yellow;background-color:black;font-weight:bold;">(colored in yellow)</span> in ''in vivo'' or in ''in vitro'' cell-culture experiments, the <scene name='Journal:JBSD:4/Cv/7'>others are not</scene> <font color='darkmagenta'><b>(in darkmagenta)</b></font>. Our main results are the following: (i) The chimeras resistant to PrP<sup>Sc</sup> infection show <scene name='Journal:JBSD:4/Cv/8'>shorter intramolecular distances</scene> between the &#945;1 helix and N-terminal of &#945;3 helix than HuPrP, MoPrP and the non-resistant chimeras (<scene name='Journal:JBSD:4/Cv/12'>click here to see morph</scene>). This is due to stronger specific interactions between these two regions, mainly the <scene name='Journal:JBSD:4/Cv/9'>Y149-D202 and D202-Y157 (in Hu numbering and hereafter) hydrogen bonds</scene> and the <scene name='Journal:JBSD:4/Cv/10'>R156-E196 salt bridge</scene>. (ii) The &#946;2-&#945;2 <scene name='Journal:JBSD:4/Cv1/2'>loop (residues 167-171)</scene> of PrP<sup>C</sup> is known to differ in its conformation across different species and is suggested to be responsible for the species barrier of PrP<sup>Sc</sup> propagation. Our simulations detect exchanges between different conformations in this loop which can be categorized into two distinct patterns: some chimeras experience a 3<sub>10</sub>-helix/turn pattern like in MoPrP and others show a bend/turn pattern like in HuPrP. In the <span style="color:lime;background-color:black;font-weight:bold;">Mo-like pattern (colored in green)</span>, 3<sub>10</sub>-helix conformation is stabilized by the <scene name='Journal:JBSD:4/Cv1/3'>Q168-P165 and Y169-V166 hydrogen bonds</scene>. In the <font color='darkred'><b>Hu-like pattern (colored in darkred)</b></font>, a <scene name='Journal:JBSD:4/Cv1/4'>D167-S170 hydrogen bond</scene> stabilizes the bend conformation. Interestingly, the dominant-negative effect of MoPrP chimeras over WT MoPrP occurs if the chimera not only resists PrP<sup>Sc</sup> infection but also adopts the Mo-like pattern of exchanges between conformations in the &#946;2-&#945;2 loop. This suggests that the compatible loop conformation allows these dominant-negative chimeras to interfere with the conversion of MoPrP to PrP<sup>Sc</sup>.
The structural features presented here indicate that stronger interactions between &#945;1 helix and N-terminal of &#945;3 helix are related to the resistance to PrP<sup>C</sup> &#8594; PrP<sup>Sc</sup> conversion, while the &#946;2-&#945;2 loop conformation may play an important role in the dominant-negative effect.
The structural features presented here indicate that stronger interactions between &#945;1 helix and N-terminal of &#945;3 helix are related to the resistance to PrP<sup>C</sup> &#8594; PrP<sup>Sc</sup> conversion, while the &#946;2-&#945;2 loop conformation may play an important role in the dominant-negative effect.
-
</StructureSection>
 
==3D structures of prion==
==3D structures of prion==
 +
[[Prion 3D structures ]]
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
+
</StructureSection>
-
{{#tree:id=OrganizedByTopic|openlevels=0|
+
-
*Prion short polypeptides
 
- 
-
**[[3nve]] – ShPrP residues 138 -143 – Syrian hamster<br />
 
-
**[[2kkg]] - PrP residues 23 -106 – Golden hamster - NMR<br />
 
-
**[[3nvf]] – hPrP residues 138 -143 – human<br />
 
-
**[[2ol9]] - hPrP residues 170 – 175<br />
 
-
**[[3nhc]], [[3nhd]], [[3md4]], [[3md5]] - hPrP residues 127 – 132<br />
 
-
**[[2iv5]] - hPrP residues 173 -195 – NMR<br />
 
-
**[[1oei]] - hPrP residues 61 - 84 – NMR<br />
 
-
**[[1oeh]] - hPrP residues 61 - 68 – NMR<br />
 
-
**[[2lbg]] - hPrP residues 110 - 136 – NMR<br />
 
-
**[[2iv6]] - hPrP residues 173 -195 (mutant) – NMR<br />
 
-
**[[2iv4]] - hPrP residues 180 -195 – NMR<br />
 
-
**[[4e1h]], [[4e1i]] - hPrP residues 177 -182 + 211-216<br />
 
-
**[[3nvg]], [[3nvh]] - mPrP residues 138 -143 – mouse<br />
 
-
**[[1skh]] - bPrP residues 1 – 30 - bovine<br />
 
-
**[[3fva]] - ePrP residues 173 -178 – Elk<br />
 
-
**[[1s4t]] - sPrP residues 135 – 155 – sheep – NMR<br />
 
-
**[[1m25]] - sPrP residues 152 – 156 – NMR<br />
 
-
**[[1g04]] - sPrP residues 145 – 169 – NMR<br />
 
-
**[[2rmv]], [[2rmw]] - sPrP residues 142 – 166 (mutant) – NMR
 
- 
-
*Prion
 
- 
-
**[[3o79]] – rPrP C-terminal – rabbit<br />
 
-
**[[4hls]], [[4hmm]], [[4hmr]]- rPrP C-terminal (mutant)<br />
 
-
**[[2fj3]] - rPrP C-terminal – NMR<br />
 
-
**[[2joh]], [[2jom]] - rPrP C-terminal (mutant) – NMR<br />
 
-
**[[1xyw]] – ePrP C terminal - NMR<br />
 
-
**[[2ku4]] - PrP C-terminal – horse<br />
 
-
**[[3fva]] - ePrP C-terminal – NMR<br />
 
-
**[[2kfl]] - PrP C-terminal – Wallaby – NMR<br />
 
-
**[[2k56]] - PrP C-terminal – Vole – NMR<br />
 
-
**[[2ktm]] – sPrP residues 167-234 H2H3 domain (mutant) – NMR<br />
 
-
**[[1xyu]], [[1y2s]] - sPrP C-terminal – NMR<br />
 
-
**[[1uw3]] - sPrP C-terminal<br />
 
-
**[[3haf]], [[3hak]], [[3hj5]], [[1i4m]] - hPrP C-terminal<br />
 
-
**[[1hjm]], [[1hjn]], [[2kun]] – hPrP C-terminal – NMR<br />
 
-
**[[1h0l]], [[1fkc]], [[2k1d]], [[1fo7]], [[1e1s]], [[1e1g]], [[1e1j]], [[1e1p]], [[1e1u]], [[1e1w]], [[1qlx]], [[1qlz]], [[1qm0]], [[1qm1]], [[1qm2]], [[1qm3]], [[1qlz]], [[1qm0]], [[1qm1]], [[2lej]]- hPrP C-terminal (mutant) - NMR<br />
 
-
**[[3heq]], [[3her]], [[3hes]], [[3hjx]] - hPrP C-terminal (mutant)<br />
 
-
**[[2lft]], [[2lsb]], [[2m8t]] - hPrP residues 90 -231 – NMR<br />
 
-
**[[2lv1]] - hPrP residues 90 -231 (mutant) – NMR<br />
 
-
**[[2lsb]] - hPrP residues 120 -230 + antibody<br />
 
-
**[[2ku5]], [[2ku6]], [[2kfm]], [[2kfo]], [[2k5o]], [[1y16]], [[1y15]] - mPrP C-terminal (mutant) - NMR<br />
 
-
**[[1xyx]] - mPrP C-terminal - NMR<br />
 
-
**[[2l1k]], [[2l1d]], [[2l1e]], [[2l40]] - mPrP C terminal (mutant) – NMR<br />
 
-
**[[1ag2]], [[2l1h]], [[2l39]] - mPrP C terminal - NMR<br />
 
-
**[[1u3m]] – PrP C-terminal – chicken – NMR<br />
 
-
**[[1u5l]] - PrP C-terminal – turtle – NMR<br />
 
-
**[[1xu0]] - PrP C-terminal – frog – NMR<br />
 
-
**[[1xyj]] - PrP C-terminal – cat – NMR<br />
 
-
**[[1xyk]] - PrP C-terminal – dog – NMR<br />
 
-
**[[1xyq]] - PrP C-terminal – pig – NMR<br />
 
-
**[[1dwy]], [[1dx0]], [[1dx1]] - bPrP C-terminal – NMR<br />
 
-
**[[1dwz]] - bPrP C-terminal (mutant) - NMR<br />
 
-
**[[1b10]] - ShPrP C-terminal – NMR<br />
 
-
**[[2lh8]] - ShPrP C-terminal + thiamine – NMR
 
- 
-
*Yeast prions
 
- 
-
**[[2onx]], [[2olx]] – Sup35 residues 8 - 11 – yeast<br />
 
-
**[[2omm]], [[1yjo]], [[1yjp]] – Sup35 residues 7 – 13<br />
 
-
**[[1jzr]], [[1k0a]], [[1k0b]], [[1k0c]], [[1k0d]] – Ure2p + glutathione derivartive<br />
 
-
**[[1g6w]], [[1g6y]] – Ure2p globular domain<br />
 
-
**[[1hqo]] – Ure2p nitrogen regulation fragment
 
- 
-
*Prion complex with antibody
 
- 
-
**[[2w9e]], [[4h88]] - hPrP C-terminal + anti-PrP antibody<br />
 
-
**[[2lsb]], [[4dgi]] - hPrP residues 120 -230 + antibody<br />
 
-
**[[4j8r]] - mPrP residues 67-82 + antibody<br />
 
-
**[[4ma7]], [[4ma8]] - mPrP residues 116 - 229 + antibody<br />
 
-
**[[2hh0]] - bPrP peptide epitope + anti-PrP antibody<br />
 
-
**[[1cu4]] - ShPrP peptide epitope + anti-PrP antibody<br />
 
-
**[[1tpx]], [[1tqb]], [[1tqc]] - sPrP C-terminal + anti-PrP antibody
 
- 
-
*HET-S from ''Podospora anserine''
 
- 
-
**[[2kj3]], [[2rnm]] – HET-S C-terminal – NMR<br />
 
-
**[[2wvn]], [[2wvo]] - HET-S N-terminal<br />
 
-
**[[2wvq]] - HET-S N-terminal (mutant)
 
-
}}
 
<references/>
<references/>
- 
- 
- 
- 
- 
- 
- 
- 
- 
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Human major prion protein complex with Cd+ (pink) and Cl- (green) ions (PDB code 3haf)

Drag the structure with the mouse to rotate
  1. Cong X, Bongarzone S, Giachin G, Rossetti G, Carloni P, Legname G. Dominant-negative effects in prion diseases: insights from molecular dynamics simulations on mouse prion protein chimeras. J Biomol Struct Dyn. 2012 Aug 30. PMID:22934595 doi:10.1080/07391102.2012.712477

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools